Article
Oncology
Kuan-Yi Lee, Chia-Ming Liu, Li-Han Chen, Chien-Yueh Lee, Tzu-Pin Lu, Li-Ling Chuang, Liang-Chuan Lai
Summary: This study aimed to investigate the role of tumor-suppressive circRNA circAAGAB in breast cancer. The findings suggest that circAAGAB, which is stabilized by interacting with RNA binding protein FUS, acts as a tumor suppressor by up-regulating the expression of KIAA1522, NKX3-1, and JADE3 through miR-378 h sponge. The results showed that circAAGAB reduced cell colony formation, cell migration, and signaling through the p38 MAPK pathway, as well as increased radiosensitivity.
CANCER CELL INTERNATIONAL
(2023)
Review
Chemistry, Medicinal
Corrado Pelaia, Alessandro Vatrella, Luca Gallelli, Nicola Lombardo, Angela Sciacqua, Rocco Savino, Girolamo Pelaia
Summary: The p38 MAPK subgroup plays a crucial role in the pathogenesis of asthma and COPD by regulating the expression of various inflammatory mediators and fibrogenic factors. Studies suggest that p38 MAPK may be a potential therapeutic target, with research evaluating its effects in both asthma and COPD treatment.
DRUG DESIGN DEVELOPMENT AND THERAPY
(2021)
Article
Multidisciplinary Sciences
Xue Wang, Yuetong Wang, Zhaoyuan Fang, Hua Wang, Jian Zhang, Longfu Zhang, Hsinyi Huang, Zhonglin Jiang, Yujuan Jin, Xiangkun Han, Shenda Hou, Bin Zhou, Feilong Meng, Luonan Chen, Kwok-Kin Wong, Jinfeng Liu, Zhiqi Zhang, Xin Zhang, Haiquan Chen, Yihua Sun, Liang Hu, Hongbin Ji
Summary: Somatic mutations of the chromatin remodeling gene ARID2 are found in around 7% of human lung adenocarcinomas, and its decreased expression is associated with lung cancer malignant progression. Knockout of ARID2 significantly promotes lung cancer progression, while knockdown of Hspa1a specifically inhibits malignant progression of ARID2-deficient lung cancers. Treatment with an HSPA1A inhibitor could significantly inhibit the malignant progression of lung cancer with ARID2 deficiency.
NATIONAL SCIENCE REVIEW
(2021)
Article
Oncology
Mikkel G. Terp, Odd L. Gammelgaard, Henriette Vever, Morten F. Gjerstorff, Henrik J. Ditzel
Summary: RAS-MAPK signaling promotes immune evasion and cancer cell survival, and MAPKi can impact the tumor microenvironment indirectly through changes in tumor cells, leading to upregulation of the immunosuppressive protein CD73. Combining anti-CD73 antibodies and MAPKi enhances antitumor effect and alters intratumor immune cell composition significantly.
MOLECULAR ONCOLOGY
(2021)
Article
Fisheries
Kexin Hua, Mingyang Wang, Yishun Jin, Yuan Gao, Rui Luo, Dingren Bi, Rui Zhou, Hui Jin
Summary: This study reveals for the first time the transcription factor Ets2 and the p38 MAPK signaling pathway mediating the expression of pig resistin during H. parasuis stimulation.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Abhilash Venugopalan, Matthew Lynberg, Constance M. Cultraro, Khoa Dang P. Nguyen, Xu Zhang, Maryam Waris, Noelle Dayal, Asebot Abebe, Tapan K. Maity, Udayan Guha
Summary: Mutant EGFRs in lung adenocarcinoma target SCAMP3, which functions as a tumor suppressor by promoting EGFR degradation and attenuating MAP kinase signaling pathways. Phosphorylation of SCAMP3 at Y86 is critical for its function, affecting cytokinesis in cells.
Article
Biochemistry & Molecular Biology
Yin Shi, Shengfeng Xu, Natalie Y. L. Ngoi, Qi Zeng, Zu Ye
Summary: Hypoxia in the tumor microenvironment, causing excessive ROS and genomic instability, is a hallmark of cancer contributing to self-renewal, metastasis, and therapy resistance. PRL-3, an oncoprotein, has been found to regulate apoptosis resistance by negatively affecting p38 MAPK activity in response to hypoxia stress.
FREE RADICAL BIOLOGY AND MEDICINE
(2021)
Review
Cell Biology
Ali Ahmadi, Sajjad Ahrari, Jafar Salimian, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi, Mostafa Ghanei
Summary: Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation caused by airway and/or alveolar remodeling. Maladjusted and self-reinforcing immune responses play a significant role in the development and progression of COPD. Targeting the p38 isoforms, which regulate immune and inflammatory responses, has shown therapeutic potential in COPD. However, clinical trials testing various p38 inhibitors have produced mixed results, and further research is needed to develop more effective therapies for COPD.
CELL COMMUNICATION AND SIGNALING
(2023)
Article
Medicine, Research & Experimental
Fangyuan Qi, Yaru Wang, Bingxin Yu, Fan Li
Summary: Our study revealed significantly decreased RECK expression in GC samples compared to normal samples, and RECK was identified as a promising predictor for the prognosis of GC patients. Moreover, upregulation of RECK demonstrated a distinctly positive association with a high-immunity and low-metastasis microenvironment in GC. Mechanistically, the antitumour effects of RECK on hampering tumor cell growth, migration, and invasion were mediated by the ERK/MAPK signaling pathway.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Multidisciplinary Sciences
Alyssa M. Kaiser, Alberto Gatto, Kathryn J. Hanson, Richard L. Zhao, Nitin Raj, Michael G. Ozawa, Jose A. Seoane, Kathryn T. Bieging-Rolett, Mengxiong Wang, Irene Li, Winston L. Trope, Douglas Z. Liou, Joseph B. Shrager, Sylvia K. Plevritis, Aaron M. Newman, Capucine Van Rechem, Laura D. Attardi
Summary: Lung cancer is the leading cause of cancer deaths worldwide, and mutations in the TP53 gene are linked to poor prognosis in lung adenocarcinomas (LUADs). This study reveals that p53 suppresses LUAD by promoting alveolar type 1 (AT1) differentiation. Through direct DNA binding, chromatin remodeling, and induction of AT1 cell characteristic genes, p53 induces an AT1 differentiation program during tumor suppression. Additionally, p53 plays a role in alveolar regeneration after injury by regulating AT2 cell self-renewal and promoting transitional cell differentiation into AT1 cells.
Article
Cell Biology
Zhihua Ye, Yingyu Yang, Ying Wei, Lamei Li, Xinyi Wang, Junkai Zhang
Summary: This study identified PCDH1 as a new prognostic marker in pancreatic ductal adenocarcinoma (PDAC) patients. PCDH1 expression was upregulated in PDAC tissues and was associated with tumor invasion depth and lymph node metastasis. Mechanistically, PCDH1 enhanced p65 nuclear localization by interacting with KPNB1, activating the NF-kappa B signaling pathway and promoting PDAC progression.
CELL DEATH & DISEASE
(2022)
Review
Pharmacology & Pharmacy
Nathalia Grave, Thamiris Becker Scheffel, Fernanda Fernandes Cruz, Liliana Rockenbach, Marcia Ines Goettert, Stefan Laufer, Fernanda Bueno Morrone
Summary: Gliomas are debilitating malignant brain tumors with limited response to therapies, driven by molecular abnormalities like mutations in regulatory networks. The MAPK pathway, particularly p38 MAPK activation, plays a crucial role in glioma cell invasion and metastasis, and is associated with tumor grade and chemotherapy resistance, underlining its potential as a therapeutic target.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Faik Imeri, Bisera Stepanovska Tanturovska, Stephanie Schwalm, Sarbari Saha, Jinyang Zeng-Brouwers, Herrmann Pavenstaedt, Josef Pfeilschifter, Liliana Schaefer, Andrea Huwiler
Summary: The study revealed that genetic depletion of Sphk2 can prevent STZ-induced nephropathy and albuminuria, and Sphk2-kd and SLM6031434 can reverse renal pathology at the cellular level. These findings suggest that Sphk2 could serve as a new attractive pharmacological target for treating proteinuric kidney diseases.
Review
Biochemistry & Molecular Biology
Yongan Song, Leonardo Kelava, Istvan Kiss
Summary: Lung cancer, particularly lung adenocarcinoma (LUAD), is a major public health challenge and the leading cause of cancer-related deaths worldwide. MicroRNAs (miRNAs) have crucial roles in gene regulation and their involvement in cancer is extensively studied. However, there is a gap in the literature regarding the specific role of miRNAs in LUAD. This review provides an inclusive overview of the research conducted on miRNAs in the context of LUAD, highlighting their potential diagnostic, prognostic, and therapeutic implications.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Anatomy & Morphology
Ziyu Dai, Bin Xie, Baishuang Yang, Xi Chen, Chengping Hu, Qiong Chen
Summary: The study shows that KANK3 gene is down-regulated in lung adenocarcinoma tissues, and its expression level is closely related to the prognosis of lung adenocarcinoma patients. Overexpression of KANK3 significantly inhibits the proliferation, invasion, and migration ability of lung adenocarcinoma cells, while silencing of KANK3 enhances these abilities. Further experiments prove that KANK3 regulates the proliferation and metastasis of lung adenocarcinoma cells through the p38 MAPK signaling pathway.
Article
Oncology
Kristen S. Hill, Evan R. Roberts, Xue Wang, Ellen Marin, Taeeun D. Park, Sorany Son, Yuan Ren, Bin Fang, Sean Yoder, Sungjune Kim, Lixin Wan, Amod A. Sarnaik, John M. Koomen, Jane L. Messina, Jamie K. Teer, Youngchul Kim, Jie Wu, Charles E. Chalfant, Minjung Kim
MOLECULAR CANCER RESEARCH
(2019)
Article
Cell Biology
Kerstin Siegmund, Nikolaus Thuille, Nina Posch, Friedrich Fresser, Michael Leitges, Gottfried Baier
CELL COMMUNICATION AND SIGNALING
(2019)
Article
Oncology
Ning Yin, Yi Liu, Andras Khoor, Xue Wang, E. Aubrey Thompson, Michael Leitges, Verline Justilien, Capella Weems, Nicole R. Murray, Alan P. Fields
Article
Biochemistry & Molecular Biology
Alexander E. Mayer, Mona C. Loeffler, Angel E. Loza Valdes, Werner Schmitz, Rabih El-Merahbi, Jonathan Trujillo Viera, Manuela Erk, Thianzhou Zhang, Ursula Braun, Mathias Heikenwalder, Michael Leitges, Almut Schulze, Grzegorz Sumara
Article
Cell Biology
Nikolaus Thuille, Kerstin Siegmund, Victoria Klepsch, Jacqueline Schoergenhuber, Sarah Danklmaier, Michael Leitges, Gottfried Baier
CELL COMMUNICATION AND SIGNALING
(2019)
Correction
Oncology
Ning Yin, Yi Liu, Andras Khoor, Xue Wang, E. Aubrey Thompson, Michael Leitges, Verline Justilien, Capella Weems, Nicole R. Murray, Alan P. Fields
Meeting Abstract
Endocrinology & Metabolism
Mini P. Sajan, Ursula Braun, Michael Leitges, Colin Park, David M. Diamond, Jin Wu, Barbara C. Hansen, Mildred Acevedo Duncan, Christopher A. Apostolatos, Andre H. Apostolatos, Mark Kindy, Robert V. Farese
METABOLISM-CLINICAL AND EXPERIMENTAL
(2020)
Article
Cell Biology
Eugene Park, Jingyu Chen, Andrew Moore, Maurizio Mangolini, Antonella Santoro, Joseph R. Boyd, Hilde Schjerven, Veronika Ecker, Maike Buchner, James C. Williamson, Paul J. Lehner, Luca Gasparoli, Owen Williams, Johannes Bloehdorn, Stephan Stilgenbauer, Michael Leitges, Alexander Egle, Marc Schmidt-Supprian, Seth Frietze, Ingo Ringshausen
SCIENCE TRANSLATIONAL MEDICINE
(2020)
Article
Multidisciplinary Sciences
Alicia K. Fleming Martinez, Heike R. Doppler, Ligia Bastea, Brandy Edenfield, Tushar Patel, Michael Leitges, Geou-Yarh Liou, Peter Storz
Summary: DCLK1(+) pancreatic cancer stem cells develop at a precancerous stage and may contribute to the lack of efficacy of pancreatic cancer therapy. Our study showed that EGFR signaling is not propagated to the nucleus in DCLK1(+) PanIN cells, and inhibition of EGFR led to a significant increase in DCLK1(+) PanIN cells. The activation of PKD1 by an increase in hydrogen peroxide is identified as a mechanism for the formation of DCLK1(+) cells, driving stemness and abundance in lesions.
Article
Medicine, General & Internal
Anthony McDowell, Kristen S. Hill, Joseph Robert McCorkle, Justin Gorski, Yilin Zhang, Ameen A. Salahudeen, Fred Ueland, Jill M. Kolesar
Summary: The study indicates that artesunate significantly reduces cell viability and induces G1 arrest in ovarian cancer cell models. Depending on the specific sequence of administration, adding artesunate to carboplatin and paclitaxel can enhance their effectiveness. Pathways related to cell cycle progression are upregulated in ovarian organoid models that are resistant to artesunate compared to sensitive models.
Article
Oncology
Kristen S. Hill, Anthony McDowell, J. Robert McCorkle, Erin Schuler, Sally R. Ellingson, Rina Plattner, Jill M. Kolesar
Summary: Artesunate, an antimalarial drug with anticancer activity, requires the involvement of the KEAP1/NRF2 pathway for its anticancer effects in non-small-cell lung cancer (NSCLC). Mutations in this pathway can affect the sensitivity of NSCLC cells to artesunate, highlighting the potential use of NRF2 inhibitors in NSCLC treatment.
Article
Oncology
Kristin S. Inman, Yi Liu, Michele L. Scotti Buzhardt, Michael Leitges, Murli Krishna, Howard C. Crawford, Alan P. Fields, Nicole R. Murray
Summary: The protein kinase C iota (PKC iota) plays a promotive role in pancreatic cancer development, and inhibition of its expression prevents pancreatic cancer formation. It also affects the autophagy of pancreatic epithelial cells and the progression of pancreatic cancer.
Article
Oncology
Hannah G. McDonald, Megan M. Harper, Kristen Hill, Anqi Gao, Angelica L. Solomon, Charles J. Bailey, Miranda Lin, Mautin Barry-Hundeyin, Michael J. Cavnar, Samuel H. Mardini, Prakash J. Pandalai, Reema A. Patel, Jill M. Kolesar, Justin A. Rueckert, Lawrence Hookey, Mark Ropeleski, Shaila J. Merchant, Joseph Kim, Mei Gao
Summary: Gastric adenocarcinoma is a major cause of cancer-related deaths worldwide. We developed a novel methodology using patient-derived organoids (PDOs) to predict chemotherapy efficacy for these patients, which can help avoid unnecessary toxicities.
Article
Cell & Tissue Engineering
Franziska von Heydebrand, Maximilian Fuchs, Meik Kunz, Simon Voelkl, Anita N. Kremer, Robert A. J. Oostendorp, Jochen Wilke, Michael Leitges, Alexander Egle, Andreas Mackensen, Gloria Lutzny-Geier
Summary: PKC beta plays a significant role in influencing glucose metabolism in CLL cells upon contact with BMSC, by stimulating glucose uptake to alleviate stress and apoptosis in CLL cells, and could potentially be targeted as a therapeutic strategy to overcome drug resistance mediated by the stromal microenvironment.
Meeting Abstract
Hematology
Eugene Park, Jingyu Chen, Andrew Moore, Michael Leitges, Seth E. Frietze, Ingo Ringshausen